Chorionic Gonadotropin Market By Type (Human Chorionic Gonadotropin (HCG), Animal Chorionic Gonadotropin), By Application (Research institutions, Pharmaceutical), By technology (Natural source extraction, Recombinant DNA technology), By therapeutic area (Female infertility treatment, Oligospermia treatment, Cryptorchidism treatment), Industry Trends, Estimation & Forecast, 2017-2025

July 2018

 Pages: 186

 ERC 4066


Chorionic Gonadotropin Market is expected to grow with a CAGR of xx% during the forecast period of 2018 to 2025.

Chorionic gonadotropin is similar to luteinizing hormone (LH) in function, which is secreted by placenta while the embryo is developing during the pregnancy. This hormone, when administrated with combination of other drugs, helps women to conceive. Apart from that, chorionic gonadotropin along with LH stimulates the production of testosterone in males.

Increasing infertility rates worldwide is the major factor which is driving the growth of chorionic gonadotropin market. As per the statistics declared by Maternal Health Task Force, today, infertility is experienced by approximately 50 million couples all around the world. Other factors which are contributing to the market growth include changing lifestyle, increasing maternity age, oligospermia, hormonal dysfunctions in both men and women, and tilting orientation of people towards hormonal drug therapies. Moreover, it has also been found that the reproductive performance of veterinary animals is also improved by the clinical use of chorionic gonadotropin extracted from human origin. For example Chorulon®, which contains the complex glycoprotein, is used in the treatment of cattle, horses, dogs, goats, pigs and queen cats for improving conception and other reproductive ailments. However, substitutes to chorionic gonadotropin treatment such as insemination and in vitro fertilization (IVF) are the challenges which can obstruct the growth of the chorionic gonadotropin market.

The report provides detailed qualitative and quantitative analysis of the chorionic gonadotropin market. Market size and forecast in terms of value and volume has been provided for the period - (2018 - 2025), for the segments namely type, application, technology, therapeutic area in each of the major regions.

Chorionic Gonadotropin Market Player Analysis -

The report presents detailed analysis of major players operating in chorionic gonadotropin market. Few of them include EMD Serono, Inc., Ferring B.V., Merck & Co., Inc., Bristol Myers Squibb Company, Fresenius KabiUSA, LLC, Scrippslabs, Leebio, Kamiya Biomedical Company, Cigna and Sanzyme.. A detailed coverage on these market players with information on their revenue from chorionic gonadotropin business, market share, gross margin and their growth strategies have been provided in the report.

Market Segmentation

Chorionic gonadotropin market is segmented on the basis of type, application, technology, therapeutic area and geography. By type, the market is segmented into human chorionic gonadotropin (HCG) and animal chorionic gonadotropin. On the basis of application, the market is categorized as research institutions, pharmaceutical, and others. By technology, the market is bifurcated as natural source extraction and recombinant DNA technology. Based on the therapeutic area, the market is categorized as female infertility treatment, oligospermia treatment, cryptorchidism treatment and others. Geographical coverage has been provided for each of the major regions including North America, Europe, Asia-Pacific, South America and Rest of the World.

Chorionic Gonadotropin Market Segmentation

By Type
• Human Chorionic Gonadotropin (HCG)
• Animal Chorionic Gonadotropin

By Application
• Research institutions
• Pharmaceutical
• Others

By technology
• Natural source extraction
• Recombinant DNA technology

By therapeutic area
• Female infertility treatment
• Oligospermia treatment
• Cryptorchidism treatment
• Others

By geography
• North America
o U.S.
o Canada
o Mexico
• Europe
o U.K.
o France
o Germany
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o China
o Japan
o India
o Korea
o Rest of APAC
• South America
o Brazil
o Rest of South America
• Rest of the World
o Middle East
o Africa

Chorionic Gonadotropin Market Key Players

• EMD Serono, Inc.
• Ferring B.V.
• Merck & Co., Inc.
• Bristol Myers Squibb Company
• Fresenius KabiUSA, LLC.
• Scrippslabs
• Leebio
• Kamiya Biomedical Company
• Cigna
• Sanzyme

Please fill in the form below to Request for Customized Report
Your personal details are safe and secured with us. Privacy Policy

To request sample copy of this report, please complete the form below verified and secure

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Your personal details are safe and secured with us. Privacy Policy

    What Information does this report contain?

    • What was the market size of the Chorionic Gonadotropin Market in 2017 and the expected market size by 2025, along with the growth rate?
    • An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
    • Which are the largest revenue generating products, services or regions and their comparative growth rate?
    • Which technology is in trend and how would it evolve during the forecast period (2017 - 2025)?
    • Which are the leading companies in the Chorionic Gonadotropin Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

Purchase Options

Offers & Discounts

  • Chapter purchase
  • Historical market data
  • Country level data breakdown
  • Free customization*
  • Discounts for first time
  • Special pricing for
              non-business entities


  • We offer 20% free customization on every purchase.

Get in touch!